NORMEDI DANMARK ApS: Financial statements 2014
CVR: 35663290
Source: annual report 2014, Danish Business Authority
13/02/2014 – 31/12/2014
NORMEDI DANMARK ApS (CVR 35663290) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 616,374 and a net result of DKK 69,731. Equity in the 2014 report amounted to DKK 119,731. The solvency ratio was 24.4%.
- Gross Profit
- DKK 616,374
- Profit/Loss
- DKK 69,731
- Equity
- DKK 119,731
- Total Assets
- DKK 490,712
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of February 14, 2014, Øystein Granne Norling is registered as director of NORMEDI DANMARK ApS.
As of February 14, 2014, Peter Andreas Stakemann has stepped down as director of NORMEDI DANMARK ApS.
On February 14, 2014, the company changed its name from ApS STAKE NR. 5035 to NORMEDI DANMARK ApS.
As of February 13, 2014, Peter Andreas Stakemann is registered as director of NORMEDI DANMARK ApS.
NORMEDI DANMARK ApS was founded on February 13, 2014.
About NORMEDI DANMARK ApS
NORMEDI DANMARK ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2014. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named ApS STAKE NR. 5035. The management consists of Jesper Steffensen. The board consists of Michelangelo Stefani (chair), Jesper Steffensen and Joao Malagueira. The company is owned by Hologic GGO 4 Ltd. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 1,460,197 and a net result of DKK 386,079 compared with DKK -74,099 the year before. Equity in the 2025 report amounted to DKK 1,852,127.